logo

Edwards Lifesciences Corp. (EW)



Trade EW now with
  Date
  Headline
9/17/2022 2:27:25 PM Edwards Lifesciences Confirms Results From CLASP IID Trial Confirms TEER As Safe, Effective Therapy In Patients With DMR
7/28/2022 4:26:15 PM Edwards Lifesciences Q2 EPS $0.65 Vs. $0.78 Year Ago
4/26/2022 4:30:44 PM Edwards Lifesciences Q1 EPS $0.59 Vs. $0.54 Year Ago
3/31/2022 9:18:03 AM Edwards Mitris Resilia Valve Obtains FDA Approval For Mitral Replacement Surgeries
12/20/2021 9:10:47 AM Edwards Lifesciences Gets FDA Approval For SAPIEN 3 With Alterra For Patients With Severe Pulmonary Regurgitation
10/27/2021 4:28:49 PM Edwards Lifesciences Q3 EPS $0.54 Vs. $0.52 Year Ago
7/29/2021 4:51:25 PM Edwards Lifesciences Corp. (EW) Has Raised Its 2021 Revenue Estimate To $5.2 - $5.4 Bln From $4.9 - $5.3 Bln